AVBP
ArriVent BioPharma, Inc. Common StockRecent alerts on AVBP
All signals →
News
ArriVent Posts Wider Loss in Fiscal Q2
14d ago
SEC filing
AVBP Announces Firmonertinib Phase 3 Data, ARR-002 Dual-Target ADC Preclinical Success, AACR 2026 Presentations
77d ago
SEC filing
AVBP Reports $312.8M Cash, $312.8M Investments, Firmonertinib Phase 3 Data Mid‑2026, ADC ARR‑217 Phase 1, NMPA Approval China
89d ago
Insider trade
Sale by HILLHOUSE INVESTMENT MANAGEMENT, LTD. / HHLR ADVISORS, LTD.
104d ago
News
$207B Market Shift: The Race for Fast Track Approval in Oncology
117d ago
Get push alerts for AVBP
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS